KR20220164741A - 중간엽 계통 전구세포 또는 줄기세포를 이용한 과염증 치료 방법 - Google Patents
중간엽 계통 전구세포 또는 줄기세포를 이용한 과염증 치료 방법 Download PDFInfo
- Publication number
- KR20220164741A KR20220164741A KR1020227037690A KR20227037690A KR20220164741A KR 20220164741 A KR20220164741 A KR 20220164741A KR 1020227037690 A KR1020227037690 A KR 1020227037690A KR 20227037690 A KR20227037690 A KR 20227037690A KR 20220164741 A KR20220164741 A KR 20220164741A
- Authority
- KR
- South Korea
- Prior art keywords
- subject
- cells
- treatment
- stem cells
- mlpscs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Developmental Biology & Embryology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020901052 | 2020-04-03 | ||
| AU2020901052A AU2020901052A0 (en) | 2020-04-03 | Method for treating hyperinflammation which comprise administering mesenchymal lineage precursor or stem cells | |
| AU2020901124A AU2020901124A0 (en) | 2020-04-08 | Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells | |
| AU2020901124 | 2020-04-08 | ||
| AU2020902312 | 2020-07-06 | ||
| AU2020902312A AU2020902312A0 (en) | 2020-07-06 | Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells | |
| AU2020902425 | 2020-07-14 | ||
| AU2020902425A AU2020902425A0 (en) | 2020-07-14 | Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells | |
| AU2020903041 | 2020-08-25 | ||
| AU2020903041A AU2020903041A0 (en) | 2020-08-25 | Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells | |
| AU2020903694 | 2020-10-12 | ||
| AU2020903694A AU2020903694A0 (en) | 2020-10-12 | Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells | |
| AU2020904312A AU2020904312A0 (en) | 2020-11-23 | Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells | |
| AU2020904312 | 2020-11-23 | ||
| PCT/EP2021/058683 WO2021198454A1 (en) | 2020-04-03 | 2021-04-01 | Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20220164741A true KR20220164741A (ko) | 2022-12-13 |
Family
ID=77927537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020227037690A Pending KR20220164741A (ko) | 2020-04-03 | 2021-04-01 | 중간엽 계통 전구세포 또는 줄기세포를 이용한 과염증 치료 방법 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230165904A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4125957A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023520233A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220164741A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115361959A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021245369A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022020042A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3173216A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021198454A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012048093A2 (en) | 2010-10-08 | 2012-04-12 | Osiris Therapeutics, Inc. | Enhanced msc preparations |
| WO2019102268A1 (en) | 2017-11-22 | 2019-05-31 | Mesoblast International Sarl | Cellular compositions and methods of treatment i |
| US12702683B2 (en) | 2019-01-03 | 2026-08-11 | Mesoblast International Sárl | Method for improving visual acuity |
| WO2021176001A1 (en) | 2020-03-05 | 2021-09-10 | Mesoblast International Sàrl | Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells |
| EP4181935A1 (en) * | 2020-07-20 | 2023-05-24 | Brainstorm Cell Therapeutics Ltd. | Methods and compositions for treating lung conditions |
| CN112826833A (zh) * | 2020-07-30 | 2021-05-25 | 中国人民解放军总医院第五医学中心 | 间充质干细胞在制备新冠肺炎引起的肺损伤修复药物中的应用 |
| US12067745B2 (en) | 2022-09-27 | 2024-08-20 | Kla Corporation | Image pre-processing for overlay metrology using decomposition techniques |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US6251295B1 (en) | 1998-01-08 | 2001-06-26 | Nexell Therapeutics Inc. | Method for recirculation washing of blood cells |
| US20080095749A1 (en) * | 2004-03-22 | 2008-04-24 | Sudeepta Aggarwal | Mesenchymal stem cells and uses therefor |
| EP2057195A4 (en) * | 2006-08-29 | 2010-05-12 | Forhumantech Co Ltd | PHARMACEUTICAL COMPOSITION FOR THE SUPPRESSION OF APOPTOSIS AND METHOD OF ADMINISTERING THE SAME |
| WO2012048093A2 (en) * | 2010-10-08 | 2012-04-12 | Osiris Therapeutics, Inc. | Enhanced msc preparations |
| US20140134140A1 (en) * | 2012-11-09 | 2014-05-15 | Case Western Reserve University | Mesenchymal stem cell compositions for the treatment of microbial infections |
| US20160199413A1 (en) * | 2013-08-01 | 2016-07-14 | Isletone Ab | Mscs in the treatment of inflammatory pulmonary diseases |
| JP6173157B2 (ja) * | 2013-10-02 | 2017-08-02 | 日本製薬株式会社 | Il−17産生抑制組成物 |
| CN110101873A (zh) * | 2018-10-27 | 2019-08-09 | 广州呼吸健康研究院 | 一种利用il-10转基因的干细胞治疗ards的方法 |
| CN110108883A (zh) * | 2018-10-27 | 2019-08-09 | 广州呼吸健康研究院 | 用于筛选与靶治疗ards患者的msc精准医学的标志物组合 |
-
2021
- 2021-04-01 JP JP2022560101A patent/JP2023520233A/ja active Pending
- 2021-04-01 WO PCT/EP2021/058683 patent/WO2021198454A1/en not_active Ceased
- 2021-04-01 US US17/995,385 patent/US20230165904A1/en active Pending
- 2021-04-01 CA CA3173216A patent/CA3173216A1/en active Pending
- 2021-04-01 KR KR1020227037690A patent/KR20220164741A/ko active Pending
- 2021-04-01 EP EP21718517.2A patent/EP4125957A1/en active Pending
- 2021-04-01 CN CN202180027057.9A patent/CN115361959A/zh active Pending
- 2021-04-01 AU AU2021245369A patent/AU2021245369A1/en active Pending
- 2021-04-01 BR BR112022020042A patent/BR112022020042A2/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023520233A (ja) | 2023-05-16 |
| BR112022020042A2 (pt) | 2022-11-22 |
| WO2021198454A1 (en) | 2021-10-07 |
| EP4125957A1 (en) | 2023-02-08 |
| AU2021245369A1 (en) | 2022-11-03 |
| US20230165904A1 (en) | 2023-06-01 |
| CA3173216A1 (en) | 2021-10-07 |
| CN115361959A (zh) | 2022-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230165904A1 (en) | Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells | |
| US11406669B2 (en) | Treatment of immune disorders | |
| US20230293589A1 (en) | Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells | |
| US20240207323A1 (en) | Method for treating acute respiratory distress syndrome (ards) using mesenchymal lineage precursor or stem cells | |
| US20230097931A1 (en) | Method for treating chronic graft versus host disease | |
| US20230104108A1 (en) | Method for treating inflammatory bowel disease ii | |
| US20230172991A1 (en) | Method for treating inflammatory bowel disease i | |
| WO2023119239A1 (en) | Method of treating severe graft versus host disease | |
| CN117337184A (zh) | 使用间充质谱系前体细胞或干细胞治疗急性呼吸窘迫综合征(ards)的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| R15-X000 | Change to inventor requested |
St.27 status event code: A-3-3-R10-R15-oth-X000 |
|
| R16-X000 | Change to inventor recorded |
St.27 status event code: A-3-3-R10-R16-oth-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |